{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:52:43Z","timestamp":1768463563547,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T00:00:00Z","timestamp":1525046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00277-018-3327-4","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T05:24:19Z","timestamp":1525065859000},"page":"1611-1618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The prognostic value of positron emission tomography\/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders"],"prefix":"10.1007","volume":"97","author":[{"given":"Satoshi","family":"Takanashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Aisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisako","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Arakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Osada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoharu","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,30]]},"reference":[{"key":"3327_CR1","first-page":"350","volume-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues","author":"P Gaulard","year":"2008","unstructured":"Gaulard P, Swerdlow SH, Harris NL, Jaffe ES, Sundstr\u00f6m C (2008) Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) World Health Organization classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 350\u2013351"},{"key":"3327_CR2","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1136\/ard.2008.093690","volume":"68","author":"C Salliot","year":"2009","unstructured":"Salliot C, van der Heijde D (2009) Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 68:1100\u20131104","journal-title":"Ann Rheum Dis"},{"key":"3327_CR3","first-page":"1741","volume":"18","author":"MH Ellman","year":"1991","unstructured":"Ellman MH, Hurwitz H, Thomas C, Kozloff M (1991) Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18:1741\u20131743","journal-title":"J Rheumatol"},{"key":"3327_CR4","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1200\/JCO.1996.14.6.1943","volume":"14","author":"E Salloum","year":"1996","unstructured":"Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Crouch J (1996) Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14:1943\u20131949","journal-title":"J Clin Oncol"},{"key":"3327_CR5","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","volume":"99","author":"X Mariette","year":"2002","unstructured":"Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J (2002) Investigators of the Club Rhumatismes et Inflammation. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 99:3909\u20133915","journal-title":"Blood"},{"key":"3327_CR6","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/0046-8177(94)90295-X","volume":"25","author":"OW Kamel","year":"1994","unstructured":"Kamel OW, van de Rijn M, LeBrun DP, Weiss LM, Warnke RA, Dorfman RF (1994) Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 25:638\u2013643","journal-title":"Hum Pathol"},{"key":"3327_CR7","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3109\/10428194.2011.625101","volume":"53","author":"M Tokuhira","year":"2012","unstructured":"Tokuhira M, Watanabe R, Nemoto T, Sagawa M, Tomikawa T, Tamaru J (2012) Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis. Leuk Lymphoma 53:616\u2013623","journal-title":"Leuk Lymphoma"},{"key":"3327_CR8","first-page":"322","volume":"34","author":"Y Hoshida","year":"2007","unstructured":"Hoshida Y, Xu JX, Fujita S, Nakamichi I, Ikeda J, Tomita Y (2007) Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34:322\u2013340","journal-title":"J Rheumatol"},{"key":"3327_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-008-9069-8","volume":"26","author":"R Rizzi","year":"2009","unstructured":"Rizzi R, Curci P, Delia M, Rinaldi E, Chiefa A, Specchia G, Liso V (2009) Spontaneous remission of \u201cmethotrexate-associated lymphoproliferative disorders\u201d after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature. Med Oncol 26:1\u20139","journal-title":"Med Oncol"},{"key":"3327_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"3327_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579\u2013586","journal-title":"J Clin Oncol"},{"key":"3327_CR12","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17:1244","journal-title":"J Clin Oncol"},{"key":"3327_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"3327_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","volume":"88","author":"E Thomas","year":"2000","unstructured":"Thomas E, Brewster DH, Black RJ, Macfarlane GJ (2000) Risk of malignancy among patients with rheumatic conditions. Int J Cancer 88:497\u2013502","journal-title":"Int J Cancer"},{"key":"3327_CR15","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1186\/ar2404","volume":"10","author":"AL Smitten","year":"2008","unstructured":"Smitten AL, Simon TA, Hochberg MC, Suissa S (2008) Meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 10:R45","journal-title":"Arthritis Res Ther"},{"key":"3327_CR16","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/ijc.24141","volume":"124","author":"LR Goldin","year":"2009","unstructured":"Goldin LR, Landgren O (2009) Autoimmunity and lymphomagenesis. Int J Cancer 124:1497\u20131502","journal-title":"Int J Cancer"},{"key":"3327_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.prp.2008.08.006","volume":"205","author":"SC Hsiao","year":"2009","unstructured":"Hsiao SC, Ichinohasama R, Lin SH, Liao YL, Chang ST, Cho CY (2009) EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate. Pathol Res Pract 205:43\u201349","journal-title":"Pathol Res Pract"},{"key":"3327_CR18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/art.21675","volume":"54","author":"E Baecklund","year":"2006","unstructured":"Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F (2006) Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54:692\u2013701","journal-title":"Arthritis Rheum"},{"key":"3327_CR19","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.3109\/10428194.2015.1022769","volume":"56","author":"Y Inui","year":"2015","unstructured":"Inui Y, Matsuoka H, Yakushijin K, Okamura A, Shimada T, Yano S (2015) Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal. Leuk Lymphoma 56:3045\u20133051","journal-title":"Leuk Lymphoma"},{"key":"3327_CR20","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/j.1349-7006.2010.01517.x","volume":"101","author":"N Niitsu","year":"2010","unstructured":"Niitsu N, Okamoto M, Nakamine H, Hirano M (2010) Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate. Cancer Sci 101:1309\u20131313","journal-title":"Cancer Sci"},{"key":"3327_CR21","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJM199305063281806","volume":"328","author":"OW Kamel","year":"1993","unstructured":"Kamel OW, van de Rijn M, Weiss LM, Del Zoppo GJ, Hench PK, Robbins BA (1993) Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328:1317\u20131321","journal-title":"N Engl J Med"},{"key":"3327_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ejh.12116","volume":"91","author":"A Ichikawa","year":"2013","unstructured":"Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Niino D (2013) Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: history, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 91:20\u201328","journal-title":"Eur J Haematol"},{"key":"3327_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1186\/s12885-016-2672-8","volume":"16","author":"S Watanabe","year":"2016","unstructured":"Watanabe S, Manabe O, Hirata K, Oyama-Manabe N, Hattori N, Kikuchi Y (2016) The usefulness of (18)F-FDG PET\/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD). BMC Cancer 16:635","journal-title":"BMC Cancer"},{"key":"3327_CR24","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/jnci\/djh313","volume":"96","author":"WH Feng","year":"2004","unstructured":"Feng WH, Cohen JI, Fischer S, Li L, Sneller M, Goldbach-Mansky R (2004) Reactivation of latent Epstein-Barr virus by methotrexate; a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst 96:1691\u20131702","journal-title":"J Natl Cancer Inst"},{"key":"3327_CR25","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1172\/JCI110127","volume":"67","author":"MA Alspaugh","year":"1981","unstructured":"Alspaugh MA, Henle G, Lennette ET, Henle W (1981) Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest 67:1134\u20131140","journal-title":"J Clin Invest"},{"key":"3327_CR26","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/art.10933","volume":"48","author":"N Balandraud","year":"2003","unstructured":"Balandraud N, Meynard JB, Auger I, Sovran H, Mugnier B, Reviron D (2003) Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum 48:1223\u20131228","journal-title":"Arthritis Rheum"},{"key":"3327_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.autrev.2004.08.034","volume":"4","author":"S Sawada","year":"2003","unstructured":"Sawada S, Takei M (2003) Epstein-Barr virus etiology in rheumatoid synovitis. Autoimmun Rev 4:106\u2013110","journal-title":"Autoimmun Rev"},{"key":"3327_CR28","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jaad.2004.03.047","volume":"51","author":"AE Adams","year":"2004","unstructured":"Adams AE, Zwicker J, Curiel C, Kadin ME, Falchuk KR, Drews R (2004) Aggressive cutaneous T-cell lymphomas after TNFalpha blockade. J Am Acad Dermatol 51:660\u2013662","journal-title":"J Am Acad Dermatol"},{"key":"3327_CR29","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1002\/art.27511","volume":"62","author":"P Diak","year":"2010","unstructured":"Diak P, Siegel J, La Grenade L, Choi L, Lemery S, McMahon A (2010) Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum 62:2517\u20132524","journal-title":"Arthritis Rheum"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3327-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3327-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3327-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T08:57:42Z","timestamp":1556614662000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3327-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,30]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["3327"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3327-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,30]]},"assertion":[{"value":"14 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from the patients. The study was approved by the Ethics Committee of Yokohama Municipal Citizen\u2019s Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}